CEL-SCI Corp.

News & Analysis

cel-sci corp. and healthcare - All News and Analysis

• Why Has Cel-Sci Quietly Amended Some Previously Filed Paperwork?

  Seeking Alpha - 2009-11-12

  Is the management at CEL-SCI Corporation CVM signaling that something big is coming? In mid September, on the same day that CEL-SCI Corporation announced that the U.S. Food and Drug Administration (FDA) had indicated that the company could proceed with its first clinical trial to evaluate the effect of its...

  Tags: Biotech, Healthcare, M. E. Garza, BioCryst Pharmaceuticals Inc., CEL-SCI Corp.

• Cel-Sci: Good News Could Lead to Long-Term Growth

  Seeking Alpha - 2009-11-10

  VFC submits: As shares of Cel-Sci Corp. CVM have traded to the upside of late, the company is set to gain more exposure when it presents at the "7th Annual Vaccines: All Things Considered Conference" in Washington, DC on Tuesday afternoon. While I don't expect the Cel-Sci stock to...

  Tags: Healthcare, VFC's Stock House, CEL-SCI Corp.

• Cel-Sci: Things Are Just Getting Started

  Seeking Alpha - 2009-10-19

  VFC submits: CVM: Shares of Cel Sci traded with continued volatility on Monday, after the company announced positive results for CEL-2000 (based on the company's LEAPS technology) in the treatment of Rheumatoid arthritis at the American College of Rheumatology Conference in Philadelphia on Sunday. It was also noted...

  Tags: Healthcare, VFC's Stock House, CEL-SCI Corp.

• Cel-Sci: Why I'm Buying if the Price Dips

  Seeking Alpha - 2009-10-14

  VFC submits: In "Readers Respond" I do my best to answer readers' questions, but keep in mind that these questions are my opinions and personal speculation that I have based on my own research and due diligence (DD). I don't invent the facts that are based in publicly available...

  Tags: Healthcare, VFC's Stock House, CEL-SCI Corp.

• Cel Sci: Job Listings Are a Good Sign

  Seeking Alpha - 2009-10-08

  VFC submits: What's left to say about Cel Sci Corp. CVM? That company and its stock have received a heck of a lot of press over the past couple of weeks and I maintain my opinion that - in my opinion - the stock will pay off based on...

  Tags: Healthcare, VFC's Stock House, CEL-SCI Corp.

• Investors Should Ignore the Hoopla Around Cel Sci

  Seeking Alpha - 2009-10-07

  VFC submits: Shares of Cel Sci CVM traded down during pre-market trading on Tuesday after The Street.com published yet another article bashing the company and the potential of its pipeline. Undoubtedly some shareholders are going to be shaken out of the stock by the antics of Feuerstein, but I...

  Tags: Healthcare, VFC's Stock House, CEL-SCI Corp.

• Cel-Sci's Positive Momentum Keeps Building

  Seeking Alpha - 2009-09-17

  For years, it seems, CEL-SCI's CVM investors have been waiting for this perfect storm of positive developments. The company was so badly beaten and on the ropes recently, that most of the management team continued to work, for extended periods of time, without compensation. "When I came home...

  Tags: Biotech, Healthcare, M. E. Garza, CEL-SCI Corp., Novavax

• Cel-Sci Thrives With New Manufacturing Facility

  Seeking Alpha - 2009-08-25

  New details have begun to emerge about Cel-Sci Corporation's CVM new, state-of-the-art "Cold-Fill" manufacturing facility which will not only be used to manufacture Multikine® the world's first immunotherapeutic agent (which is being developed as a first-line standard of care treatment for cancer) for both the Phase III trials and commercial...

  Tags: Biotech, Healthcare, M. E. Garza, CEL-SCI Corp.

• CEL-SCI CEO's Bullish Biotech Play

  Seeking Alpha - 2009-08-23

  CEL-SCI's CVM CEO is suddenly feeling more confident than ever. Who can blame him? There are verified reports that the company's biotechnology activates the immune system and targets the H1N1 flu's hemagglutinin molecule. The treatment apparently induces a defined immune response which could help infected swine...

  Tags: Biotech, Healthcare, M. E. Garza, CEL-SCI Corp.

• Not Buying Cel Sci's Swine Flu PR

  Seeking Alpha - 2009-08-18

  VFC submits: Shares of Cel Sci Corp. CVM enjoyed a small spike to over fifty cents after the company released yet another press release relating its LEAPS technology for the treatment of the H1N1 Swine Flu. According to the PR, the company has expanded the scope towards creating...

  Tags: Biotech, Healthcare, VFC's Stock House, CEL-SCI Corp.